CORRECTED-MDxHealth signs U.S. marketing partnership for cancer test
(Corrects in second paragraph to remove reference to company securing U.S. approval earlier this month; adds test available since May 2012.)
BRUSSELS, July 29 (Reuters) - Belgium-based cancer testing company MDxHealth said on Monday it had signed a partnership with Bostwick Laboratories Inc to market prostate cancer test ConfirmMDx in the United States.
MDxHealth said the partnership would grant it access to one of the largest urology networks in the country, where the test has been available since May 2012.
DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.